| Product Code: ETC7372928 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of intravenous antibodies to Grenada in 2024 showed a diversification of sources, with top exporting countries including Saint Lucia, Barbados, Ireland, USA, and Trinidad and Tobago. The Herfindahl-Hirschman Index (HHI) indicated a shift from high to moderate concentration from 2023 to 2024, reflecting a more balanced market landscape. Despite a negative Compound Annual Growth Rate (CAGR) of -3.58% from 2020 to 2024, there was a positive growth rate of 3.24% from 2023 to 2024, suggesting potential opportunities for market expansion and development in the coming years.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Grenada Intravenous Antibodies Market Overview |
3.1 Grenada Country Macro Economic Indicators |
3.2 Grenada Intravenous Antibodies Market Revenues & Volume, 2021 & 2031F |
3.3 Grenada Intravenous Antibodies Market - Industry Life Cycle |
3.4 Grenada Intravenous Antibodies Market - Porter's Five Forces |
3.5 Grenada Intravenous Antibodies Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Grenada Intravenous Antibodies Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Grenada Intravenous Antibodies Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Grenada Intravenous Antibodies Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Grenada Intravenous Antibodies Market Trends |
6 Grenada Intravenous Antibodies Market, By Types |
6.1 Grenada Intravenous Antibodies Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Grenada Intravenous Antibodies Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Grenada Intravenous Antibodies Market Revenues & Volume, By IgG, 2021- 2031F |
6.1.4 Grenada Intravenous Antibodies Market Revenues & Volume, By IgA, 2021- 2031F |
6.1.5 Grenada Intravenous Antibodies Market Revenues & Volume, By IgM, 2021- 2031F |
6.1.6 Grenada Intravenous Antibodies Market Revenues & Volume, By IgE, 2021- 2031F |
6.1.7 Grenada Intravenous Antibodies Market Revenues & Volume, By IgD, 2021- 2031F |
6.2 Grenada Intravenous Antibodies Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Grenada Intravenous Antibodies Market Revenues & Volume, By Immunodeficiency Diseases, 2021- 2031F |
6.2.3 Grenada Intravenous Antibodies Market Revenues & Volume, By Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), 2021- 2031F |
6.2.4 Grenada Intravenous Antibodies Market Revenues & Volume, By Idiopathic Thrombocytopenic Purpura, 2021- 2031F |
6.2.5 Grenada Intravenous Antibodies Market Revenues & Volume, By Hypogammaglobulinemia, 2021- 2031F |
6.2.6 Grenada Intravenous Antibodies Market Revenues & Volume, By Myasthenia Gravis, 2021- 2031F |
6.2.7 Grenada Intravenous Antibodies Market Revenues & Volume, By Multifocal Motor Neuropathy, 2021- 2031F |
6.2.8 Grenada Intravenous Antibodies Market Revenues & Volume, By Others, 2021- 2031F |
6.2.9 Grenada Intravenous Antibodies Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Grenada Intravenous Antibodies Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Grenada Intravenous Antibodies Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Grenada Intravenous Antibodies Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.4 Grenada Intravenous Antibodies Market Revenues & Volume, By Others, 2021- 2031F |
7 Grenada Intravenous Antibodies Market Import-Export Trade Statistics |
7.1 Grenada Intravenous Antibodies Market Export to Major Countries |
7.2 Grenada Intravenous Antibodies Market Imports from Major Countries |
8 Grenada Intravenous Antibodies Market Key Performance Indicators |
9 Grenada Intravenous Antibodies Market - Opportunity Assessment |
9.1 Grenada Intravenous Antibodies Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Grenada Intravenous Antibodies Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Grenada Intravenous Antibodies Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Grenada Intravenous Antibodies Market - Competitive Landscape |
10.1 Grenada Intravenous Antibodies Market Revenue Share, By Companies, 2024 |
10.2 Grenada Intravenous Antibodies Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |